CAIBX
Price
$81.53
Change
-$0.15 (-0.18%)
Updated
Jun 23 closing price
Net Assets
127.98B
CIRAX
Price
$81.50
Change
-$0.15 (-0.18%)
Updated
Jun 23 closing price
Net Assets
127.98B
Interact to see
Advertisement

CAIBX vs CIRAX

CAIBX vs CIRAX Comparison Chart in %
View a ticker or compare two or three
VS
CAIBX vs. CIRAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAIBX is a Hold and CIRAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CAIBX (128B) and CIRAX (128B) have equal amount of cash in the bank . CAIBX (2.73) and CIRAX (2.70) have matching dividends . CAIBX was incepted earlier than CIRAX: CAIBX (39 years) vs CIRAX (24 years). CIRAX (0.60) and CAIBX (0.58) have similar cost to investors . CAIBX (50.00) and CIRAX (50.00) have comparable annual turnover. CAIBX initial investment is less costly to investors than CIRAX (4%) vs CIRAX (4%). CAIBX (250) and CIRAX (250) have matching initial minimum investment requirements. CAIBX (11.90) and CIRAX (11.87) have marching annual gain over last year. CIRAX return over 5 years is better than : 40.03 vs. CAIBX (36.71).
CAIBXCIRAXCAIBX / CIRAX
Total Expense Ratio0.580.6097%
Annual Report Gross Expense Ratio0.580.6097%
Fund Existence39 years24 years-
Gain YTD7.2857.288100%
Front Load6%4%164%
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets128B128B100%
Annual Yield % from dividends2.732.70101%
Returns for 1 year11.9011.87100%
Returns for 3 years41.3741.27100%
Returns for 5 years36.7140.0392%
Returns for 10 years71.8799.6872%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGHSX40.340.43
+1.08%
Invesco Health Care R6
HFMTX31.41N/A
N/A
Hartford MidCap R5
SGGCX55.89N/A
N/A
DWS Large Cap Focus Growth C
GBLAX41.90-0.25
-0.59%
American Funds Global Balanced A
DFETX27.49-1.53
-5.27%
DFA Emerging Markets II